Armistice Capital »

Cadrenal Therapeutics shares owned by Armistice Capital

Quarter-by-quarter ownership of Cadrenal Therapeutics (CVKD) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Cadrenal Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cadrenal Therapeutics held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cadrenal Therapeutics by Armistice Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $668k 982k 0.68

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Argenx Se Sponsored Adr (ARGX)
Supernus Pharmaceuticals (SUPN)
Ptc Therapeutics I (PTCT)
Neurocrine Biosciences (NBIX)
Agios Pharmaceuticals (AGIO)
Biogen Idec (BIIB)
Colgate-Palmolive Company (CL)
Travere Therapeutics (TVTX)
Nevro (NVRO)
Amazon (AMZN)
Dentsply Sirona (XRAY)
Regeneron Pharmaceuticals (REGN)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Armistice Capital

Top funds holding Cadrenal Therapeutics

Honkamp Krueger Financial Services
Wells Fargo & Company

View all funds holding Cadrenal Therapeutics